14,414 Shares in CVS Health Co. (NYSE:CVS) Purchased by Cary Street Partners Financial LLC

Cary Street Partners Financial LLC bought a new stake in shares of CVS Health Co. (NYSE:CVS - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 14,414 shares of the pharmacy operator's stock, valued at approximately $647,000.

Several other large investors have also recently made changes to their positions in the business. Ridgewood Investments LLC increased its position in shares of CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock valued at $28,000 after acquiring an additional 450 shares in the last quarter. Stonebridge Financial Group LLC purchased a new position in shares of CVS Health during the 4th quarter valued at $28,000. Hopwood Financial Services Inc. purchased a new position in shares of CVS Health during the 4th quarter valued at $29,000. Financial Perspectives Inc lifted its stake in shares of CVS Health by 137.5% during the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock valued at $36,000 after buying an additional 466 shares in the last quarter. Finally, Compass Planning Associates Inc purchased a new stake in CVS Health in the 4th quarter worth $37,000. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have recently weighed in on CVS shares. Wolfe Research boosted their target price on shares of CVS Health from 67.00 to 70.00 and gave the stock an "overweight" rating in a report on Tuesday, February 11th. JPMorgan Chase & Co. upped their target price on shares of CVS Health from $80.00 to $81.00 and gave the stock an "overweight" rating in a research note on Tuesday, February 18th. Cowen restated a "buy" rating on shares of CVS Health in a research note on Monday, May 5th. Cantor Fitzgerald raised shares of CVS Health from a "neutral" rating to an "overweight" rating in a research report on Wednesday, February 12th. Finally, Leerink Partners raised shares of CVS Health from a "market perform" rating to an "outperform" rating and increased their target price for the company from $55.00 to $75.00 in a research report on Thursday, February 13th. Three research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $74.94.

Insider Activity

In related news, Director Michael F. Mahoney acquired 30,000 shares of the company's stock in a transaction on Tuesday, February 18th. The shares were purchased at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the purchase, the director now owns 39,356 shares in the company, valued at $2,625,045.20. This represents a 320.65% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP James David Clark sold 7,513 shares of the business's stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the sale, the senior vice president now directly owns 8,394 shares of the company's stock, valued at $556,941.90. This represents a 47.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.22% of the stock is owned by company insiders.

CVS Health Trading Down 3.3%

Shares of CVS traded down $2.24 during mid-day trading on Monday, hitting $64.74. The company had a trading volume of 20,508,456 shares, compared to its average volume of 11,448,492. The business's 50-day simple moving average is $66.96 and its 200-day simple moving average is $59.06. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $72.51. The stock has a market cap of $81.89 billion, a PE ratio of 17.69, a P/E/G ratio of 0.98 and a beta of 0.60.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating the consensus estimate of $1.62 by $0.63. The firm had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. CVS Health's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.31 earnings per share. Sell-side analysts forecast that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd were given a dividend of $0.665 per share. The ex-dividend date was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.11%. CVS Health's dividend payout ratio (DPR) is presently 63.48%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.